Deborah Crouch

Array ( [id] => 790750 [patent_doc_number] => 06984772 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-10 [patent_title] => 'Transgenic non-human mammals producing fibrinogen in their milk' [patent_app_type] => utility [patent_app_number] => 08/443184 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 121 [patent_no_of_words] => 13951 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/984/06984772.pdf [firstpage_image] =>[orig_patent_app_number] => 08443184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1164092 [patent_doc_number] => 06759392 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'High affinity RNA ligands of basic fibroblast growth factor' [patent_app_type] => B1 [patent_app_number] => 08/442423 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 16758 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759392.pdf [firstpage_image] =>[orig_patent_app_number] => 08442423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4078316 [patent_doc_number] => 05965789 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals' [patent_app_type] => 1 [patent_app_number] => 8/434834 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14398 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965789.pdf [firstpage_image] =>[orig_patent_app_number] => 434834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3724669 [patent_doc_number] => 05700671 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Methods of making transgenic animals producing oligosaccharides and glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/434151 [patent_app_country] => US [patent_app_date] => 1995-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 14910 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700671.pdf [firstpage_image] =>[orig_patent_app_number] => 434151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989874 [patent_doc_number] => 05891698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Oligosaccharides and glycoproteins produced in milk of transgenic non-human mammals' [patent_app_type] => 1 [patent_app_number] => 8/433271 [patent_app_country] => US [patent_app_date] => 1995-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 14901 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891698.pdf [firstpage_image] =>[orig_patent_app_number] => 433271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4024687 [patent_doc_number] => 05902576 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Antitumor pharmaceutical composition comprising IL-6 transfected cells' [patent_app_type] => 1 [patent_app_number] => 8/430248 [patent_app_country] => US [patent_app_date] => 1995-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 8013 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902576.pdf [firstpage_image] =>[orig_patent_app_number] => 430248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047958 [patent_doc_number] => 05912410 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Transgenic non-human mice displaying the amyloid-forming pathology of alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/422333 [patent_app_country] => US [patent_app_date] => 1995-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 44 [patent_no_of_words] => 26493 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912410.pdf [firstpage_image] =>[orig_patent_app_number] => 422333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4090347 [patent_doc_number] => 06018097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Transgenic mice expressing human insulin' [patent_app_type] => 1 [patent_app_number] => 8/419850 [patent_app_country] => US [patent_app_date] => 1995-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6767 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/018/06018097.pdf [firstpage_image] =>[orig_patent_app_number] => 419850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768110 [patent_doc_number] => 05849572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'HSV-1 vector containing a lat promoter' [patent_app_type] => 1 [patent_app_number] => 8/411920 [patent_app_country] => US [patent_app_date] => 1995-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5457 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849572.pdf [firstpage_image] =>[orig_patent_app_number] => 411920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854361 [patent_doc_number] => 05767336 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Gene trap vectors comprising a type II transmembrane domain' [patent_app_type] => 1 [patent_app_number] => 8/404727 [patent_app_country] => US [patent_app_date] => 1995-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6125 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767336.pdf [firstpage_image] =>[orig_patent_app_number] => 404727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768096 [patent_doc_number] => 05849571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Latency active herpes virus promoters and their use' [patent_app_type] => 1 [patent_app_number] => 8/401638 [patent_app_country] => US [patent_app_date] => 1995-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9774 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849571.pdf [firstpage_image] =>[orig_patent_app_number] => 401638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3739213 [patent_doc_number] => 05698765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Mouse having a disrupted CD4 gene' [patent_app_type] => 1 [patent_app_number] => 8/400173 [patent_app_country] => US [patent_app_date] => 1995-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 21 [patent_no_of_words] => 4318 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698765.pdf [firstpage_image] =>[orig_patent_app_number] => 400173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834727 [patent_doc_number] => 05814716 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Cell lines from a transgenic mouse which express biologically active IX factor' [patent_app_type] => 1 [patent_app_number] => 8/394210 [patent_app_country] => US [patent_app_date] => 1995-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8017 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814716.pdf [firstpage_image] =>[orig_patent_app_number] => 394210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826645 [patent_doc_number] => 07402308 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-07-22 [patent_title] => 'Method of delivering genes to the central nervous system of a mammal' [patent_app_type] => utility [patent_app_number] => 08/393066 [patent_app_country] => US [patent_app_date] => 1995-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8317 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402308.pdf [firstpage_image] =>[orig_patent_app_number] => 08393066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890547 [patent_doc_number] => 05723719 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Transgenic mouse as model for diseases involving dopaminergic dysfunction' [patent_app_type] => 1 [patent_app_number] => 8/389191 [patent_app_country] => US [patent_app_date] => 1995-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5498 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723719.pdf [firstpage_image] =>[orig_patent_app_number] => 389191 [rel_patent_id] =>[rel_patent_doc_number] =>)